CS
APVO icon

Clear Street’s Aptevo Therapeutics APVO Stock Holding History

Clear Street’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8
Closed -$3.25K – 684
2025
Q1 		$3.25K Buy
+8
New +$10.1K ﹤0.01% 445

Other funds holding APVO

BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Clear Street's APVO Position: Q2 2025 in Review

Clear Street sold out of Aptevo Therapeutics (APVO) in Q2 2025, closing a stake of 8 shares — an estimated $3.25K sold.

Clear Street first reported a position in APVO in Q1 2025 and held it in 1 quarter. The position peaked at $3.25K in Q1 2025. 4 funds tracked by Wall St. Rank hold APVO as of Q2 2025.

  • Clear Street reported no remaining Aptevo Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Clear Street sold 8 Aptevo Therapeutics shares in Q2 2025, an estimated $3.25K.
  • Clear Street first reported a position in Aptevo Therapeutics in Q1 2025 and held it in 1 quarter.
  • Clear Street's Aptevo Therapeutics position peaked at $3.25K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Aptevo Therapeutics as of Q2 2025.

Based on Clear Street's 13F filing for Q2 2025, filed 13 Aug 2025.